Related Experiment Video
Updated: May 20, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Current management approaches for congenital melanocytic nevi
Sven Krengel1, Ashfaq A Marghoob
1Department of Dermatology, University of Lübeck, Ratzeburger Allee 160, Lübeck, Germany.
Abstract:
Lack of information and misinformation abounds regarding the potential risks of malignancy, management approaches, benefits of surgical intervention, follow-up strategies, and overall prognosis for individuals with congenital melanocytic nevi (CMN). This review is intended to provide answers to questions that frequently arise shortly after the birth of individuals with CMN, especially of larger types.
Insights
Congenital melanocytic nevi (CMN) information is often lacking or incorrect. This review addresses key questions about CMN risks, management, surgery, follow-up, and prognosis for newborns, particularly those with large nevi.
Area of Science:
- Dermatology
- Pediatric Medicine
- Genetics
Background:
- Congenital melanocytic nevi (CMN) are common birthmarks.
- Significant information gaps and misinformation exist regarding CMN.
- Parents frequently have urgent questions about CMN shortly after birth.
Purpose of the Study:
- To consolidate current knowledge on congenital melanocytic nevi.
- To address common parental concerns about CMN.
- To provide evidence-based guidance on CMN management and prognosis.
Main Methods:
- Comprehensive literature review.
- Synthesis of existing research on CMN.
- Expert consensus on management strategies.
Main Results:
- Detailed overview of CMN classification and prevalence.
- Assessment of malignancy risk associated with different CMN types.
- Discussion of surgical and non-surgical management options.
- Guidance on appropriate follow-up protocols.
- Prognostic factors influencing long-term outcomes.
Conclusions:
- Accurate information is crucial for managing congenital melanocytic nevi.
- Personalized management plans are essential for optimal outcomes.
- Further research is needed to refine understanding and treatment of CMN.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

